AstraZeneca is backing up its considerable ... Chief executive Pascal Soriot said the plant will help AZ achieve its ambition to position ADCs as a replacement for traditional chemotherapies ...
CAMBRIDGE, England, November 12, 2024--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and ...
(Reuters) -Drugmaker AstraZeneca lifted its annual sales and ... announcing $2 billion in new spending on research and development and on plants that manufacture biologics medicines and cell ...
(Reuters) -Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time ... The London-listed company doubled down on plans for U.S. expansion, announcing $2 billion in new ...